Senhwa develops cancer therapies and advances a pipeline with CX-5461, CX-4945 for solid tumours and haematological malignancies. Credit: Sai Thaw Kyar / Shutterstock.com. Senhwa Biosciences has completed enrolment in its Phase Ib expansion trial of pidnarulex (CX-5461) as a monotherapy for people with advanced solid tumours carrying breast cancer gene 1/2 (BRCA1/2) or partner and…
The all-cash deal is expected to close next month, after which Headspace’s wellness services will live under the same roof as Sword's virtual care platform, according to a filing with Massachusetts regulators. Source link
Researchers estimate that independent dispute resolution has created $22 billion in unnecessary spending. But that estimate is flawed, argue associations representing anesthesiologists, radiologists and ER doctors. Source link
Suki says its dictation tool, which can be integrated into Epic and Meditech, offers a highly accurate transcription that can be useful for clinicians working with complex medical jargon. Source link
The attack affected global operations, and its full scope is still being determined, the medical device maker said in a securities filing. Source link
Multiple myeloma is a form of blood cancer involving abnormal proliferation of plasma cells in bone marrow. Credit: Hadayeva Sviatlana/Shutterstock.com. HaemaLogiX has treated the first patient with its KMCAR T-cell therapy as part of the Phase I KOALA clinical trial for relapsed or refractory kappa-restricted multiple myeloma. The trial is being conducted at the Peter…
Accelerating dispute volumes and sky-high award amounts are inflating how much independent dispute resolution is costing the U.S., according to new Georgetown research. Patients could pay the price with higher premiums. Source link
Monogram, a home health company, overcharged Medicare through contracts with Cigna and Humana by inflating diagnostic codes, according to the Justice Department. Source link
Precision Medicine Group will operate within McKesson once the transaction receives final regulatory and closing approvals. Credit: Piotr Swat / Shutterstock.com. US-based healthcare services provider McKesson has agreed to buy Precision Medicine Group for $2.25bn. McKesson believes that the deal will support its clinical research and biopharmaceutical commercialisation services. Discover B2B Marketing That Performs Combine…
More than 65% of physicians use AI daily or weekly for clinical or administrative work — and some believe they should be paid more if the tech increases their efficiency, according to a Doximity report. Source link
